Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07301905 · ClinicalTrials.gov registry record · NA
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
A NA study of HPV Vaccination, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 265
- Enrollment target
- 1
- Study location
NCT07301905: Recruiting NA study of HPV Vaccination, sponsored by Michigan State University.
NCT07301905 is a NA study of HPV Vaccination that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 265 participants, below the 621-participant average among 4 other HPV Vaccination trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07301905, a NA study of HPV Vaccination, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 265 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is: • Does culturally targeted messaging increase African American parents' intentions to vaccinate their daughter against HPV? Research will compare culturally targeted messaging to general, educational messaging and no messaging. Participants will: * View culturally targeted messages, education-only messages, or no messages about the HPV vaccine * Report their intentions to vaccinate their daughter against HPV * Report whether they have initiated HPV vaccination for their daughter six months later
Primary Outcome
Subscale of Theory of Planned Behavior measuring attitudes toward the HPV vaccine on response scale ranging from 1 = Strongly disagree to 7 = Strongly agree, where higher average scores indicate more positive attitudes
Conditions Studied
Interventions
- BEHAVIORAL General HPV Vaccine Health Messaging
- BEHAVIORAL Culturally Targeted HPV Vaccine Health Messaging
Study Locations (1)
Michigan
- Flint Journal Building - Flint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2024-11-17 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT07301905 shows while recruiting
NCT07301905 is an interventional study that assigns participants to a tested intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap, below the 621-participant average among 4 other HPV Vaccination trials with a reported enrollment target (57% lower).
The record links to 1 condition, with HPV Vaccination appearing as the primary indexed condition, and to 2 interventions - of which General HPV Vaccine Health Messaging is the first listed.
NCT07301905 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT07301905 about?
NCT07301905 is a clinical study titled "Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI". The goal of this clinical trial is to learn if culturally targeted messaging about the human papillomavirus (HPV) increases receptivity to the HPV vaccine among African American parents of vaccine-eligible daughters. The main question it aims to answer is: • Does culturally targeted messaging incre...
What is the current status of trial NCT07301905?
This trial is currently recruiting. It is a NA study. The enrollment target is 265 participants. The study started on 2024-11-17. Estimated completion is 2026-06.
What conditions does trial NCT07301905 study?
This clinical trial studies the following conditions: HPV Vaccination.
What interventions are being tested in trial NCT07301905?
The interventions under investigation include: General HPV Vaccine Health Messaging (BEHAVIORAL), Culturally Targeted HPV Vaccine Health Messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT07301905?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07301905 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HPV Vaccination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
ACTIVE NOT RECRUITING · NA
-
PREVENT HPV -Related Cancers Trial
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Implementation and Effectiveness of IPP-HPV
COMPLETED · NA
-
Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American Children
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443126 · 265 participants · Phase 1
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- NCT05470491 · 265 participants · Phase 1
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- NCT07470853 · 265 participants · Phase 1
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI